Top Markets
#1 GEKKO GEKKO +52.86%
#2 Helium Helium +51.20%
#3 Siren Siren +26.90%
#4 Pons Pons +22.87%
#5 Main Street Yield Main Street Yield +17.48%
#6 龙虾 (Lobster) 龙虾 (Lobster) +15.82%
#7 Nillion Nillion +14.76%
#8 Collect on Fanable Collect on Fanable +14.29%
#9 Cysic Cysic +13.45%
#10 o1.exchange o1.exchange +13.41%
Coin of the day
GEKKO GEKKO
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Kolon TissueGene, Inc. Kolon TissueGene, Inc.

Kolon TissueGene, Inc.

950160
Kedudukan dalam Saham #9085
Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the... Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the advancement of clinical-stage cell-based treatments for osteoarthritis. Its flagship offering is TG-C, a proprietary platform technology that integrates allogeneic primary cells with genetically engineered counterparts. Established by Kwan H. Lee on June 9, 1999, the enterprise maintains its corporate headquarters in Rockville, Maryland.
Harga Saham
$12.94
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$1.10B
Perubahan (1 hari)
-0.16%
Perubahan (1 tahun)
-51.50%
Negara
US
Perdagangan Kolon TissueGene, Inc. (950160)

Kategori

Healthcare
Sejarah harga saham bagi Kolon TissueGene, Inc. (950160)
Harga penutupan tertinggi: $14.96 pada 2026-08-01

Harga penutupan terendah: $50.89 pada 2017-11-01
Sejarah harga saham Kolon TissueGene, Inc. dari 2017 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -2.28%
2025 232.88%
2024 144.93%
2023 -18.79%
2022 -12.44%
2019 -73.89%
2018 -22.36%
2017 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH